Stay updated on Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision v3.3.4 was added and Revision v3.3.3 was removed as footer metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:32:34.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The study status is now Terminated, side effect 'rash' has been added to the adverse events, and completion/enrollment dates have been updated.
    Difference
    0.7%
    Check dated 2025-12-24T23:25:41.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Locations section added with Illinois as a location; Illinois Locations and HHS Vulnerability Disclosure removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-17T19:47:50.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T08:43:22.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The warning banner about potential delays due to government funding has been removed from the page. This does not affect the study data, enrollment criteria, or results presented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T08:11:09.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    No substantive changes detected to core study information (eligibility criteria, endpoints, or trial status); observed differences appear to be minor UI rendering variations between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T02:57:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page.